Deleterious effects of interruption followed by reintroduction of enzyme replacement therapy on a lysosomal storage disorder

作者：Schneider Ana Paula; Matte Ursula^*; Pasqualim Gabriela; Vicente Tavares Angela Maria; Mayer Fabiana Quoos; Martinelli Barbara; Ribas Graziela; Vargas Carmen Regla; Giugliani Roberto; Baldo Guilherme

来源：Translational Research, 2016, 176: 29-37.

DOI：10.1016/j.trsl.2016.05.002

Temporary interruption of enzyme replacement therapy (ERT) in patients with different lysosomal storage disorders may happen for different reasons (adverse reactions, issues with reimbursement, logistic difficulties, and so forth), and the impact of the interruption is still uncertain. In the present work, we studied the effects of the interruption of intravenous ERT (Laronidase, Genzyme) followed by its reintroduction in mice with the prototypical lysosomal storage disorder mucopolysaccharidosis type I, comparing to mice receiving continuous treatment, untreated mucopolysaccharidosis type I mice, and normal mice. In the animals which treatment was temporarily interrupted, we observed clear benefits of treatment in several organs (liver, lung, heart, kidney, and testis) after reintroduction, but a worsening in the thickness of the aortic wall was detected. Furthermore, these mice had just partial improvements in behavioral tests, suggesting some deterioration in the brain function. Despite worsening is some disease aspects, urinary glycosaminoglycans levels did not increase during interruption, which indicates that this biomarker commonly used to monitor treatment in patients should not be used alone to assess treatment efficacy. The deterioration observed was not caused by the development of serum antienzyme antibodies. All together our results suggest that temporary ERT interruption leads to deterioration of function in some organs and should be avoided whenever possible.

• 出版日期2016-10